Communiqués de presse Archive - Page 15 of 21 - Ose Immunotherapeutics - Société de biotechnologie intégrée qui développe des immunothérapies innovantes

OSE Immunotherapeutics Presentation at H.C. Wainwright Global Life Sciences Conference

OSE Immunotherapeutics Announces Granting of First European Patent Protecting OSE-127

OSE Immunotherapeutics Enters a Loan Agreement of up to €25 Million with the European Investment Bank

OSE Immunotherapeutics Expands its Collaboration with MAbSilico

INCREASE IN RESOURCES DEVOTED TO THE LIQUIDITY CONTRACT OSE IMMUNOTHERAPEUTICS

OSE Immunotherapeutics Receives €1.3 Million Milestone Payment from Bpifrance for OSE-127/S95011

OSE Immunotherapeutics Presentation at H.C. Wainwright BIOCONNECT 2021

OSE Immunotherapeutics Announces Enrolment of First Patient with Ulcerative Colitis in Phase 2

OSE Immunotherapeutics Receives €5.2 M in Public Funding

OSE Immunotherapeutics and Nantes University Hospital Announce Initiation of a Phase 1/2 of FR104

Précédent
1
…
12
13
14
15
16
17
18
…
21
Suivant